Relationships between vascularization and proliferation in invasive breast cancer

Journal of Pathology

Volumn 189, Issue 3, 1999, Pages 309-318

  Beliën, Jeroen A M ^a   Van Diest, Paul J ^a   Baak, Jan P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Breast cancer; Image analysis; Mitosis; Necrosis; Proliferation

Indexed keywords

ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL COUNT; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MITOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR NECROSIS; VASCULARIZATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROCIRCULATION; MITOSIS; NECROSIS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0032868402     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199911)189:3<309::AID-PATH457>3.0.CO;2-0     Document Type: Article

References (52)

1. Fox SB. Tumour angiogenesis and prognosis. Histopathology 1997; 30: 294-301.
2. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 1998; 184: 119-122.
3. Folkman J. Tumour angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
4. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-1763.
5. Rak J, Filmus J, Kerbel RS. Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer 1996; 32A: 2438-2450.
6. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-188.
7. Jacquemier JD, Penault-Llorca FM, Bertucci F, et al. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol 1998; 184: 130-135.
8. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147: 9-19.
9. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992; 23: 755-761.
10. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995; 177: 275-283.
11. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994; 12: 454-466.
12. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120-1124.
13. Obermair A, Kurz C, Czerwenka K, et al. Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer 1995; 62: 126-131.
14. Ogawa Y, Chung Y-S, Nakata B, et al. Microvessel quantitation in invasive breast cancer by staining for Factor VIII-related antigen. Br J Cancer 1995; 71: 1297-1301.
15. Ravazoula P, Hatjikondi O, Kardamakis D, Maragoudakis M, Bonikos D. Angiogenesis and metastatic potential in breast carcinoma. Breast 1996; 5: 418-421.
16. Simpson JF, Ahn C, Battifora H, Esteban JM. Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 1996; 77: 2077-2085.
17. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993; 55: 371-374.
18. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-1887.
19. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
20. Tannock IF. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 1968; 22: 258-273.
21. Tannock IF, Steel GG. Quantitative techniques for study of the anatomy and function of small blood vessels in tumors. J Natl Cancer Inst 1969; 42: 771-782.
22. Brammer I, Zywietz F, Jung H. Changes of histological and proliferative indices in the Walker carcinoma with tumour size and distance from blood vessel. Eur J Cancer 1979; 15: 1329-1336.
23. Gabbert H, Wagner R, Höhn P. The relation between tumor cell proliferation and vascularization in differentiated and undifferentiated colon carcinomas in the rat. Virchows Arch [Cell Pathol] 1982; 41: 119-131.
24. Hirst DG, Denekamp J. Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet 1979; 12: 31-42.
25. Paulus G, Xiang Hong Li, Atassi G, Buyssens N. Degree of differentiation and blood vessel proximity in B16 melanoma. Virchows Arch [Cell Pathol] 1982; 39: 229-238.
26. Kaldjian EP, Long J, Davenport RD, Lloyd RV. Immunohistochemical analysis of hormone receptors, tumor vascularity, and proliferative activity in paraffin-embedded sections of breast carcinoma tissues. Appl Immanohistochem 1993; 1: 31-38.
27. Monschke F, Müller W-U, Winkler U, Streffer C. Cell proliferation and vascularization in human breast carcinomas. Int J Cancer 1991; 49: 812-815.
28. Klijanienko J, El-Naggar AK., De Braud F, et al. Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 1995; 75: 1649-1656.
29. Lauk S, Skates S, Goodman M, Suit HD. A morphometric study of the vascularity of oral squamous cell carcinomas and its relation to outcome of radiation therapy. Eur J Cancer Clin Oncol 1989; 25: 1431-1440.
30. Smolle J, Soyer HP, Hofmann-Wellenhof R, Smolle-Juettner FM, Kerl H. Vascular architecture of melanocytic skin tumors: a quantitative immunohistochemical study using automated image analysis. Pathol Res Pract 1989; 185: 740-745.
31. Rabes HM, Carl P, Meister P, Rattenhuber U. Analysis of proliferative compartments in human tumors. Cancer 1979; 44: 799-813.
32. Aranda FI, Laforga JB. Microvessel quantification in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases. Pathol Res Pract 1996; 192: 124-129.
33. De Jong JS, Van Diest PJ, Van der Valk P, Baak JPA. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlation with proliferation and angiogenesis. J Pathol 1998; 184: 53-57.
34. Fox SB, Gatter KC, Bicknell R, et al. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993; 53: 4161-4163.
35. Kato T, Kimura T, Miyakawa R, et al. Clinicopathologic study of angiogenesis in Japanese patients with breast cancer. World J Surg 1997; 21: 49-56.
36. Kawaguchi T, Yamamoto S, Kudoh S, Goto K, Wakasa K, Sakurai M. Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma. Anticancer Res 1997; 17: 3743-3746.
37. Marinho A, Soares R, Ferro J, Lacerda M, Schmitt FC. Angiogenesis in breast cancer is related to age but not to other prognostic factors. Pathol Res Pract 1997; 193: 267-273.
38. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994; 144: 1188-1194.
39. De Jong JS, Van Diest PJ, Baak JPA. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 1995; 73: 922-926.
40. Axelsson K, Ljung BME, Moore DH, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995; 87: 997-1008.
41. Barbareschi M, Weidner N, Gasparini G, et al. Microvessel density quantification in breast carcinomas: assessment by light microscopy vs. a computer-aided image analysis system. Appl Immunohist 1995; 3: 75-84.
42. Beliën JAM, Somi S, De Jong JS, Van Diest PJ, Baak JPA. Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 1999; 52: 184-192.
43. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone, 1987.
44. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992; 40: 1457-1463.
45. Beliën JAM, Baak JPA, Van Diest PJ, Van Ginkel AHM. Counting mitoses by image processing in Feulgen stained breast cancer sections: the influence of resolution. Cytometry 1997; 28: 135-140. (Erratum appears in Cytometry 1997; 29: 189.)
46. Ten Kate TK, Beliën JAM, Smeulders AWM, Baak JPA. Method for counting mitoses by image processing in Feulgen stained breast cancer sections. Cytometry 1993; 14: 241-250.
47. Baak JPA. Mitotis counting in tumors (Editorial). Hum Pathol 1990; 21: 683-685.
48. Baak JPA. Counting mitoses. In: Baak JPA, ed. Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Berlin: Springer-Verlag, 1991: 169-172.
49. Goldacre RJ, Sylven B. On the access of blood-borne dyes to various tumour regions. Br J Cancer 1962; 16: 306-322.
50. Baish JW, Netti PA, Jain RK. Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Microvasc Res 1997; 2: 128-141.
51. Boehm T, Folkman J, Browder T, O'Reily MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404-407.
52. Jannink I, Van Diest PJ, Baak JPA. Comparison of the prognostic value of mitotic activity index (MAI), random MAI (rMAI), M/V-index, and random M/V-index (rM/V-index) in breast cancer patients. Hum Pathol 1995; 26: 1086-1092.